Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington’s Disease Progression

ABSTRACT: This is a case control study consisting of 36 HD patients, more specifically of asymptomatic (n=18), early symptomatic (n=10) and symptomatic advanced (n=8) and 36 gender/age matched controls. A blood sample was collected from all study participants, using a standard protocol serum was extracted and stored at -80°C degrees until time of sample preparation and analysis.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Serum

DISEASE(S): Huntington Disease

SUBMITTER: Christiana Christodoulou  

LAB HEAD: Eleni Zamba

PROVIDER: PXD053477 | Pride | 2025-08-04

REPOSITORIES: Pride